Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 3Glioblastoma 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Osteonecrosis 1Osteomyelitis 1Neurodegenerative Diseases 1Malignant Solid Neoplasm 1Kidney Neoplasms 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Head and Neck Neoplasms 1Glioma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Childhood Brain Neoplasm 1Central Nervous System Vascular Malformations 1Central Nervous System Infections 1Carcinoma, Medullary 1Cancer of Lymph Node 1

Interventions

Laser Speckle Contrast Imaging 2Tissue Array Analysis 1Magnetic Resonance Spectroscopy 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Central Nervous System Vascular Malformations × Ferrosoferric Oxide × Clear all
NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Stanford University

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡